Clopidogrel Proton-Pump Inhibitors Study.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 25 Oct 2016
At a glance
- Drugs Clopidogrel; Omeprazole; Pantoprazole
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 19 Oct 2016 Status changed from suspended to withdrawn prior to enrolment since the published data resolved the study goals we decided not to start it.
- 23 Jun 2011 Planned end date changed from 1 Feb 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 23 Jun 2011 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.